Innate Pharma Announces New Clinical Data for Lacutamab and SAR443579/IPH6101 at ASH 2023
MARSEILLE, France--(BUSINESS WIRE)--Nov 3, 2023--
Source: valdostadailytimes.com
First In Human Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from First In Human Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In First In Human Study Today - Breaking & Trending Today
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC
/PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation,...
Source: prnewswire.com
Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13
Management to host conference call and webcast on October 13 at 4:30 PM ET with key opinion leader and KB-0742 trial investigator, Miguel Villalona-Calero, M.D., of City of HopeSAN MATEO, Calif., and...
Source: marketscreener.com
RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy and Highlights New Research at ASTRO 2023 Meeting
Data from 19 scientific presentations validate efficacy of SCINTIX therapy
Source: itnonline.com
Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023 - Arrowhead Pharma (NASDAQ:ARWR)
- Arrowhead Expands the Reach of RNAi Therapies to Address Diseases in the Lung - Late-Breaking Clinical Data for ARO-RAGE for Treatment of Asthma Demonstrate Deep and Durable Gene Silencing - Promising Preclinical
Source: benzinga.com